These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36090051)

  • 1. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
    Corbett V; Hallenbeck P; Rychahou P; Chauhan A
    Front Mol Biosci; 2022; 9():930207. PubMed ID: 36090051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth.
    Evans DJ; Wasinger AM; Brey RN; Dunleavey JM; St Croix B; Bann JG
    Front Oncol; 2018; 8():506. PubMed ID: 30460197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Seneca Valley Virus: past perspectives and future directions.
    Burke MJ
    Oncolytic Virother; 2016; 5():81-9. PubMed ID: 27660749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus.
    Miles LA; Burga LN; Gardner EE; Bostina M; Poirier JT; Rudin CM
    J Clin Invest; 2017 Aug; 127(8):2957-2967. PubMed ID: 28650343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1.
    Cao L; Zhang R; Liu T; Sun Z; Hu M; Sun Y; Cheng L; Guo Y; Fu S; Hu J; Li X; Yu C; Wang H; Chen H; Li X; Fry EE; Stuart DI; Qian P; Lou Z; Rao Z
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13087-13092. PubMed ID: 30514821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection.
    Jayawardena N; Miles LA; Burga LN; Rudin C; Wolf M; Poirier JT; Bostina M
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33924774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus.
    Jayawardena N; Burga LN; Easingwood RA; Takizawa Y; Wolf M; Bostina M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10934-E10940. PubMed ID: 30381454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.
    Reddy PS; Burroughs KD; Hales LM; Ganesh S; Jones BH; Idamakanti N; Hay C; Li SS; Skele KL; Vasko AJ; Yang J; Watkins DN; Rudin CM; Hallenbeck PL
    J Natl Cancer Inst; 2007 Nov; 99(21):1623-33. PubMed ID: 17971529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Assessment of the Health Risk for Livestock When Animal Viruses Are Applied in Human Oncolytic Therapy: A Case Study for Seneca Valley Virus.
    Schijven J; Brizee S; Teunis P; de Vos C; Eblé P; Rutjes S
    Risk Anal; 2019 May; 39(5):982-991. PubMed ID: 30395685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Structure-Guided Genetic Modification Strategy: Developing Seneca Valley Virus Therapy against Nonsensitive Nonsmall Cell Lung Carcinoma.
    Zhao Z; Cao L; Sun Z; Liu W; Li X; Fang K; Shang X; Hu J; Chen H; Lou Z; Qian P
    J Virol; 2023 May; 97(5):e0045923. PubMed ID: 37097154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seneca Valley virus replicons are packaged in
    Bryant JD; Lee JS; De Almeida A; Jacques J; Chang CH; Fassler W; Quéva C; Lerner L; Kennedy EM
    Mol Ther Oncolytics; 2023 Mar; 28():321-333. PubMed ID: 36938543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of a Seneca Valley virus thermostable mutant.
    Jayawardena N; McCarthy C; Wang I; Waqqar S; Burga LN; Strauss M; Bostina M
    Virology; 2022 Oct; 575():74-82. PubMed ID: 36084546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.
    Rudin CM; Poirier JT; Senzer NN; Stephenson J; Loesch D; Burroughs KD; Reddy PS; Hann CL; Hallenbeck PL
    Clin Cancer Res; 2011 Feb; 17(4):888-95. PubMed ID: 21304001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed Evolution of Seneca Valley Virus in Tumorsphere and Monolayer Cell Cultures of a Small-Cell Lung Cancer Model.
    Waqqar S; Lee K; Lawley B; Bilton T; Quiñones-Mateu ME; Bostina M; Burga LN
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.
    Poirier JT; Reddy PS; Idamakanti N; Li SS; Stump KL; Burroughs KD; Hallenbeck PL; Rudin CM
    J Gen Virol; 2012 Dec; 93(Pt 12):2606-2613. PubMed ID: 22971818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus.
    Venkataraman S; Reddy SP; Loo J; Idamakanti N; Hallenbeck PL; Reddy VS
    Structure; 2008 Oct; 16(10):1555-61. PubMed ID: 18940610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viruses: From bench to bedside with a focus on safety.
    Buijs PR; Verhagen JH; van Eijck CH; van den Hoogen BG
    Hum Vaccin Immunother; 2015; 11(7):1573-84. PubMed ID: 25996182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seneca Valley Virus 2C and 3C
    Liu T; Li X; Wu M; Qin L; Chen H; Qian P
    Front Microbiol; 2019; 10():1202. PubMed ID: 31191506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic virotherapy for pediatric malignancies: future prospects.
    Waters AM; Friedman GK; Ring EK; Beierle EA
    Oncolytic Virother; 2016; 5():73-80. PubMed ID: 27579298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.